NYSE$FTRE
Fortrea Holdings Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
Fortrea reported Q4 2025 results with adjusted net income of $40M after goodwill impairment.
Adjusted net income was approximately $40 million excluding goodwill impairment and other charges. The CRO is repositioning its portfolio after separation from Labcorp with focus on biotech and specialty trials.
- Adjusted profitability ex impairments.
- CRO demand from biotech sponsors.
- Portfolio repositioning post-spin.
- Free cash flow focus.
Headline financials
Revenue & EPS history
Fortrea · Revenue · Quarterly
$661M
Forward guidance
2026 emphasizes book-to-bill, adjusted margins, and capital discipline in clinical services.
Tailwinds
- Adjusted earnings exclude one-time impairments.
- Biotech outsourcing tailwinds.
Headwinds
- Goodwill and restructuring overhang on GAAP.
- Trial start-up delays from sponsors.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports · overlaid with Q4 2025
+1.3%
Avg return
Earnings day
-0.8%
Avg return
5 days after
+0.5%
Avg return
30 days after
53%
8 / 15 earnings
Positive
+26.0%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +18.5% | +25.9% | +40.5% | |
| Q4 2025 | +4.9% | +1.4% | -12.3% | |
| Q3 2025 | +23.4% | +15.3% | +46.8% | |
| Q1 2025 | -15.6% | -27.8% | -11.7% | |
| Q4 2024 | -25.1% | -22.9% | -45.8% | |
| Q3 2024 | +26.0% | +17.9% | +20.1% | |
| Q2 2024 | -11.7% | -11.4% | -18.4% | |
| Q1 2023 | -1.9% | -3.9% | -9.9% | |
| Q1 2024 | -12.7% | -16.6% | -24.8% | |
| Q4 2021 | +3.0% | +4.9% | +2.7% | |
| Q4 2023 | +3.2% | +6.7% | +6.0% | |
| Q3 2022 | +15.1% | -6.6% | -4.0% | |
| Q3 2023 | +15.1% | +13.0% | +14.1% | |
| Q2 2022 | -11.3% | +6.7% | +9.5% | |
| Q2 2023 | -11.3% | -14.9% | -5.9% | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro